The clustering between hypertension and other metabolic abnormalities related to insulin resistance syn- 
Introduction
Insulin resistance syndrome (IRS), characterized by clustering of hypertension, hyperlipidemia, obesity, and glucose intolerance in the same individuals, has been well documented by epidemiological studies (1) (2) (3) . Based on the data from both cross-sectional and prospective studies, insulin resistance and/or its compensatory hyperinsulinemia are speculated to be the underlying defects responsible for this metabolic syndrome (2, 4) . Among these clustered metabolic abnormalities, the association between insulin and blood pressure (BP) is the most variable and challenged (5, 6) .
The familial component of IRS has been demonstrated in both family (7, 8) and twin studies (9) (10) (11) . These studies have estimated the heritability of the variables related to IRS, suggesting that IRS is determined by both genetic and environmental factors. The heritability, however, was usually estimated in diabetic twins. Therefore, the significance of the genetic correlation between insulin and BP has not been well explored. It has been shown that low insulin sensitivity or clustering characteristics of metabolic abnormalities are more commonly observed in normotensive offspring of hypertensive parents than in those without hypertension in their family history (12) (13) (14) . However, it is not known whether siblings (sibs) in a family with a history of hypertension have different degrees of insulin sensitivity.
To investigate the genetic factors responsible for hypertension and insulin resistance, a family study, the StanfordAsian Pacific Program in Hypertension and Insulin Resistance (SAPPHIRe), was conducted in 1995. This multi-center study investigated two types of sib pairs: concordant sib pairs who both had hypertension (HTN), and discordant sib pairs in which one sib had HTN and one sib had low BP (LBP). In the present study, we investigated whether sibs with different levels of BP had different metabolic profiles. The clustering of hypertension and the other components of IRS were examined within families, and the heritability of the metabolic variables related to IRS was estimated from these hypertensive families. To our knowledge, it has not been shown directly whether degrees of insulin sensitivity or clustering of metabolic abnormalities would be correlated among siblings with different levels of BP.
Methods

Study Population
The study population was based on the SAPPHIRe to identify genetic determinants that influence susceptibility to hypertension and insulin resistance in Chinese and Japanese. This human genetic study has been approved by the institutional review board of each field center/hospital, and all participants gave their informed written consent. The details of the SAPPHIRe have been described previously (15) . Briefly, the SAPPHIRe network consists of six field centers in Taiwan, Hawaii and Stanford University. The study design recruited both concordant sib-pairs (both sibs with HTN) and discordant sib-pairs (one hypertensive and one LBP sib) from either Chinese or Japanese descendants. However, sibs with BP levels that did not fit the criteria of HTN or LBP were also recruited.
Subjects were recruited based on the following criteria. 1) A current age of between 35 and 60 years. Subjects currently over 60 were also eligible provided that documentation of their hypertension status prior to age 60 was available. 2) Chinese or Japanese ancestries; i.e., all four grandparents were either Chinese or Japanese. 3) HTN was defined as systolic BP (SBP) ≥160 mmHg or diastolic BP (DBP) ≥95 mmHg, or the current use of 2 medications for high BP. Alternatively, the subject could have uncontrolled hypertension; i.e., either SBP ≥140 mmHg or DBP ≥90 mmHg and current use of one medication for high BP. 4) LBP was defined as BP in the bottom 30% of the age-and sex-adjusted BP distribution from a general population recruited from 1993-1996 in Taiwan (16) . Thus, for males under age 45, LBP was defined as SBP ≤115 mmHg and DBP ≤76 mmHg, and for those over 45, it was defined as SBP ≤122 mmHg and DBP ≤78 mmHg. For females younger than 45, LBP was defined as SBP ≤107 mmHg and DBP ≤70 mmHg, and for those over 45, the cut-off was SBP ≤118 mmHg and DBP ≤75 mmHg. As long as both SBP and DBP readings were below the limit, there was no upper age cut-off for LBP sibs. However, LBP sibs were required to meet the lower age cutoff.
BP was recorded automatically according to a common protocol by using the DINAMAP TM Vital Signs Monitor (Model 1846 SX/P; Critikon Inc., Tampa, USA). After subjects had rested in a seated position for 10 min, three separate readings were taken with intervals of 1 min. The average of the second and the third readings was used for analysis. Body mass index (BMI) was defined as weight (kg)/ [height (m)] 2 , and waist/hip ratio (WHR) as waist circumference divided by hip circumference; all of these measurements were made in the standard manner.
Families were excluded from the study if they met any of the following criteria. 1) One of the affected sibs was adopted (i.e., no parent in common), or the sibs had only one parent in common. 2) Both parents had been treated for hypertension before the age of 60. If the offspring's reports about their parents hypertension status were conflicting, then a single reliable report of hypertension in both parents before the age of 60 was used for exclusion. This exclusion criterion, however, did not apply to discordant sib-pairs. 3) One or both of the affected sibs was diabetic. 4) One or both of the affected sibs had severe renal disease characterized by serum creatinine 0.133 mmol/l, unless documented proof that the subject met inclusion criteria prior to the elevation of serum creatinine level. 5) One or both of the affected sibs had BMI greater than 35 kg/m 2 . In addition, the following conditions were considered as cause for exclusion: 1) Subjects with ongoing (or within the past 6 months) treatment for malignancy; 2) terminal illness (life expectancy 6 months); 3) cirrhosis or any other chronic illness (e.g. heart disease); 4) pregnancy or 6 months post-partum.
In all, there were 2,525 subjects recruited from the six field centers. Seventy-seven percent of subjects recruited at the Stanford field center were of Chinese descent. The majority (85%) of subjects recruited at the Hawaii field center were of Japanese descent, and all subjects recruited at the Taiwan field centers were Chinese. Over 65% of the total number of subjects were recruited in Taiwan. Of these subjects, 48% were diagnosed with HTN and 19% with LBP.
Laboratory
A 75-g oral glucose tolerance test (OGTT) was conducted on all subjects. Subjects with fasting plasma glucose levels greater than 6.99 mmol/l were excluded. The concentrations of plasma glucose, lipids, and insulin were measured by the previously described methods (17) . The homeostasis model assessment (HOMAIR) index (fasting insulin ( µIU/ml) fasting glucose (mmol/l)/ 22.5) was used to estimate the degree of insulin resistance (18) .
Statistical Analysis
Only families with both HTN and LBP sibs were included in the analysis. Since the variables were not normally distributed, appropriate transformations were adopted on each variable and the transformed variables were analyzed. In order to study the metabolic differences between the HTN-LBP discordant sibs, each variable was adjusted by age, gender, and log-transformed BMI. Two statistical methods, the delta method and variance component model, were applied to compare the differences in metabolic variables between HTN and LBP sibs.
Delta Method
For the adjusted metabolic variable, the mean difference of HTN and LBP sibs within the family was estimated. The delta method was then used to test whether there were differences between HTN and LBP sibs among all families. Let n be the number of eligible families and µi1 and µi2 be the means of adjusted metabolic variables of the HTN and LBP group, respectively, in the ith family (i 1, 2, , n). The delta method is used to test the null hypothesis: µ11 µ12 µ21 µ22 µn1 µn2 0. The analyses were performed using SAS Version 8.2 software (SAS Institute Inc., Cary, USA). The PROC GLM program was used to derive the estimates of µi1 and µi2 for each family, and to perform the delta method.
Variance Components Model
In this method, the BP status (HTN or LBP) was treated as a fixed effect. The differences in the metabolic variables between HTN and LBP were analyzed with this model by testing the null hypothesis that there was no difference in the adjusted variables between HTN-LBP discordant sibs in the presence of background polygenic variance.
For estimation of heritability, the variance of each adjusted variable was partitioned into genetic and environmental components. , where σa 2 is the additive genetic variance and σd 2 is the dominant genetic variance. All variance components were estimated from covariances among relatives from families. In practice, this variance components model estimates the genetic component of variance as well as the effect of the BP status in the presence of the genetic component of variance. All models were fitted by the maximal likelihood procedures, as implemented in the SOLAR software package (Southwest Foundation for Biomedical Research, San Antonio, USA) (19) .
Data were expressed as the mean SD. All statistical tests were two-sided and p-values less than 0.05 were considered to indicate statistical significance.
Results
Characteristics of the HTN and LBP Sibs
Among the 734 families, there were 268 families (232 Chinese and 36 Japanese) that had at least one HTN and one LBP sib. From these families, 393 HTN and 389 LBP subjects were enrolled for analysis. Among LBP sibs, the ratio of female to male subjects was higher than among HTN sibs 
Differences in Metabolic Variables between HTN and LBP
Delta method analysis showed that HTN sibs had higher levels of TG ( p 0.0001), very low density lipoprotein (VLDL) ( p 0.0001) and fasting insulin ( p 0.032) than LBP sibs, but there were no differences in total cholesterol, HDL-cholesterol, LDL-cholesterol or fasting glucose between the two groups ( Table 2 ). There were 32 sibs who had been taking either 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) inhibitors (23) or fibrates (9) . However, after excluding these subjects, the differences of lipid variables between the HTN (n 356) and LBP (n 365) sibs remained similar (data not shown). Each variable was adequately transformed with a corresponding factor in both methods. Data are expressed as the mean SD before transformations. The differences were analyzed by the delta method (method 1) and variance component model (method 2), and adjusted for gender, age and log (BMI). BMI, body mass index; WHR, waist/hip ratio; TG, triglyceride; Glu0, Glu60, Glu120, Ins0, Ins60, and Ins120, the glucose and insulin levels at fasting, and 1-h and 2-h after 75-g glucose oral load, respectively; HOMAIR, homeostasis model assessment of insulin resistance ( fasting insulin ( µIU/ml) fasting glucose (mmol/l) / 22.5). Subjects taking α-blockers or ACEI were excluded. The differences were analyzed by the delta method after adjusting for age, gender, and BMI. Only the families with HTN sibs who were discordant with respect to the use of antihypertensive medications. Abbreviations are the same as shown in (data not shown). In analysis with the variance components model, the significance of the differences in these metabolic variables between HTN and LBP sibs was similar to that analyzed by the delta method (Table 2) . Accordingly, HTN sibs had more unfavorable metabolic factors related to IRS than did LBP sibs.
Effects of Antihypertensive Medications on Metabolic Variables
Among the 393 HTN sibs, 351 patients (89.1%) had been taking antihypertensive drugs on recruitment. Half of them (49%) took two kinds of antihypertensive drugs, and 33 (9.4%) of them took three kinds. The most frequently prescribed antihypertensive drug was calcium channel blocker (52%), followed by β-blocker (47.1%), angiotensin converting enzyme (ACE) inhibitor (ACEI) (27.3%), diuretics (19%) and α-blocker (11.1%).
Because of the complexity of antihypertensive medications in these subjects, we only analyzed the influences of β-blockers and diuretics, which may aggravate insulin resistance in hypertensive subjects (20) . In addition, the effects of α-blockers and ACEI were adjusted, because these two drugs have been reported to have favorable effects on insulin sensitivity (20, 21) .
After adjusting medications with β-blockers and/or diuretics (B/D) in HTN sibs, the differences in metabolic variables between HTN and LBP sibs remained significant (data not shown). Furthermore, when only the families with HTN sibs who were discordant in regard to their use of B/D medication were enrolled for analysis, HTN sibs who had been taking B/D but without α-blockers or ACEI showed no differences in metabolic variables, except LDL cholesterol, from their HTN sibs who did not take B/D (Table 3) . Similar results were obtained when the subjects taking lipid-lowering drugs were excluded, except that sibs taking B/D had modest increase of VLDL cholesterol ( p 0.05, data not shown).
Heritabilities of the Metabolic Variables
Estimation of the genetic component from these 268 families showed significant heritability for all the metabolic variables ( p 0.0001), with h 2 values ranging from 0.31 to 0.63 (Table 4) . After adjustment for BP status, age, BMI and gender, the heritability estimates for each lipid level were approximately 0.60. The heritability for fasting insulin was lower than that for fasting glucose, with estimates of 0.43 and 0.58, respectively. As the index of insulin resistance, HOMAIR has an h 2 value of 0.46, similar to that for the area under the curve of insulin (h 2 0.45). The anthropometrical variables had a heritability of 0.54 and 0.52 for BMI and WHR, respectively, after adjusting for age and gender.
When all eligible sibs were enrolled for calculation, there were 505 families including 959 HTN, 391 LBP and 367 sibs with their BP not fitting the criteria of HTN and LBP.
The heritability values estimated from these 505 families were similar to those estimated for the 268 families above (Table 4) .
Discussion
Family studies have shown that the association of hypertension and insulin resistance and/or hyperinsulinemia possesses familial components. Both normotensive and hypertensive offspring of hypertensive parents show greater incidence of hyperinsulinemia, reduced insulin sensitivity, and dyslipidemia than offspring of normotensive parents (12) (13) (14) . The Artherosclerosis Risk in Communities (ARIC) study also shows that offspring have an increased risk of multiple metabolic syndrome when their parents had a history of hypertension in combination with diabetes mellitus (8) . These results suggested that the clustering characteristic of IRS is heritable, and the genetic factor(s) responsible for insulin resistance may be closely linked to the genes conferring susceptibility to hypertension. This speculation is now further supported by the results of the present hypertensive sib study. Both the delta method and variance component model analyses showed that HTN sibs had unfavourable metabolic factors related to IRS as compared with their LBP counterparts.
The association between hypertension and some components related to IRS has been questioned. The controversial observations may result from the different study populations that were confounded by obesity, ethnicity, diabetic status, or medications. For example, the effect of obesity may confound the relationship between insulin resistance and hypertension (6, 22) . In the present study, the HTN sibs had a greater BMI, and BMI was independently associated with all the variables of glucose homeostasis. However, after adjustment of BMI, HTN sibs still had higher TG, fasting insulin and HOMAIR. Despite the fact that there was no difference in HDL levels between HTN and LBP sibs, we showed signifi- (22, 24, 25) . The reason for the discrepancy is not clear, but differences related to race/ethnicity may be involved. Plasma lipid levels and insulin sensitivity per se could be altered by antihypertensive medications. It has been shown that insulin resistance can be aggravated by β-blockers and diuretics, but improved by α-blockers and ACEI (20, 21) . Several studies have demonstrated a higher incidence of NIDDM in hypertensive subjects treated with β-blockers/ thiazides (23, 26) . However, no effect of these two drugs on insulin sensitivity was observed in Mexican-Americans and Chinese (27, 28) . In the present analysis of HTN sibs who were discordant with respect to mediations, we demonstrated that β-blockers/thiazides have no effect on the metabolic variables related to IRS. The significant difference of the variables related to glucose homeostasis between HTN and LBP suggests that genes conferring susceptibility to the development of hypertension may be closely linked with the genes leading to insulin resistance. From this sib population, we obtained significant heritabilities for all metabolic variables related to IRS. Several twin studies have revealed that both genetic and environmental factors contribute to the development of insulin resistance (9 -11) . These studies have demonstrated that most, although not all, of the metabolic variables associated with insulin level are genetically dependent. The heritability values calculated from the present cohort may not be extensible to the general population of hypertensive families. The fact that a greater heritability was obtained in the present study than in the previous twin studies may be due to the dichotomous classification of sibs into HTN and LBP resulting in a higher inter-individual genetic variation (29) . On the other hand, because not all sibs were recruited for analysis, the maximum-likelihood estimates of the genetic sources of variability are generally underestimated (30) . We therefore added calculations from all eligible sibs and obtained very similar results. In fact, the heritabilities for the components of IRS were compatible with the values of other studies, with the exception of the estimate for fasting insulin.
Because hyperinsulinemia is a hallmark of insulin resistance, fasting insulin levels are usually used as an index of insulin resistance. Varying degrees of heritability for fasting insulin, ranging from 0.26 to 0.54, had been calculated from twin studies (10, 31, 32) . Accordingly, it has been questioned whether genetic factors contribute to the development of IRS. The divergent results may result from a sampling bias, e.g., with respect to race, disease status, ascertainment of twins, etc. A family study of 98 sedentary Caucasian families with parental data disclosed a low heritability of fasting insulin (33) in comparison with the value from our sib study (0.21 vs. 0.43). The higher heritability from our study may suggest that fasting insulin level is more heritable in hypertension families. This observation may also support the notion of a close association between the genes regulating BP and fasting insulin.
In a number of studies, HOMAIR has been used as the index of insulin resistance (18, 32, 34) . The heritability for HOMAIR from our study was 0.46, compatible with the values from twin studies (11, 32) . The estimate was similar to the heritability for fasting insulin. Therefore, in terms of insulin resistance, fasting insulin and HOMAIR have the same heritability in these hypertensive families. Several studies have estimated a higher h 2 value (0.50-0.60) for fasting glucose than for fasting insulin (31, 32, 34) . In the present study, the heritability for fasting glucose was 0.58, and that for 2-h glucose was 0.60. This data supports the notion that insulin secretion is more genetically dependent than insulin sensitivity (32, 35) .
The genetic influences on adiposity measures in Caucasians are significant for weight and BMI, with heritabilities more than 0.70 (9, 32, 33) . In contrast, the heritability for WHR or abdominal visceral fat are not consistent, ranging from 0.06 to 0.89. This discrepancy may be due to differences among the populations with respect to gender, age, or status of diabetes. In the present study, the heritabilities for weight, BMI and WHR were significant, with estimates around 0.55. These results suggest that the genetic influences on anthropometric variables in Asian people, although significant, were not as pronounced as those in Western populations. Both twin and family studies have revealed substantial
